165 related articles for article (PubMed ID: 19891692)
21. Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration.
Paltrinieri S; Crippa A; Comerio T; Angioletti A; Roccabianca P
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):68-74. PubMed ID: 17521745
[TBL] [Abstract][Full Text] [Related]
22. Hormonal background of canine and feline mammary tumours.
Rutteman GR; Misdorp W
J Reprod Fertil Suppl; 1993; 47():483-7. PubMed ID: 8229967
[TBL] [Abstract][Full Text] [Related]
23. Immunological effects of recombinant feline interferon-omega (KT-80) administration in the dog.
Kuwabara M; Nariai Y; Horiuchi Y; Nakajima Y; Yamaguchi Y; Horioka E; Kawanabe M; Kubo T; Yukawa M; Sakai T
Microbiol Immunol; 2006; 50(8):637-41. PubMed ID: 16924149
[TBL] [Abstract][Full Text] [Related]
24. Treatment of a case of refractory feline chronic gingivostomatitis with feline recombinant interferon omega.
Southerden P; Gorrel C
J Small Anim Pract; 2007 Feb; 48(2):104-6. PubMed ID: 17286664
[TBL] [Abstract][Full Text] [Related]
25. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
Morikawa K; Fidler IJ
J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
[TBL] [Abstract][Full Text] [Related]
27. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
[TBL] [Abstract][Full Text] [Related]
28. Canine mammary tumour cell lines established in vitro.
Hellmén E
J Reprod Fertil Suppl; 1993; 47():489-99. PubMed ID: 8229968
[TBL] [Abstract][Full Text] [Related]
29. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
[TBL] [Abstract][Full Text] [Related]
30. Cloning, Prokaryotic Soluble Expression, and Analysis of Antiviral Activity of Two Novel Feline IFN-ω Proteins.
Wang X; Li F; Han M; Jia S; Wang L; Qiao X; Jiang Y; Cui W; Tang L; Li Y; Xu YG
Viruses; 2020 Mar; 12(3):. PubMed ID: 32204464
[TBL] [Abstract][Full Text] [Related]
31. Feline interferon-omega treatment on canine parvovirus infection.
Minagawa T; Ishiwata K; Kajimoto T
Vet Microbiol; 1999 Sep; 69(1-2):51-3. PubMed ID: 10515269
[TBL] [Abstract][Full Text] [Related]
32. Clinical trial results on the use of a recombinant feline interferon-omega to protect Japanese pearl oysters Pinctada fucata martensii from akoya-virus infection.
Miyazaki T; Nozawa N; Kobayashi T
Dis Aquat Organ; 2000 Oct; 43(1):15-26. PubMed ID: 11129377
[TBL] [Abstract][Full Text] [Related]
33. [Tumor cells and extracellular matrix with special reference to mamma tumors in dogs and cats].
Nederbragt H; Vos JH; van Niel MH; Misdorp W
Tijdschr Diergeneeskd; 1990 Oct; 115(20):948-57. PubMed ID: 2281472
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer.
Frimberger AE; Moore AS; Cincotta L; Cotter SM; Foley JW
Clin Cancer Res; 1998 Sep; 4(9):2207-18. PubMed ID: 9748141
[TBL] [Abstract][Full Text] [Related]
35. Modulation of anthracycline activity in canine mammary tumour cells in vitro by medroxyprogesterone acetate.
Pagnini U; Florio S; Lombardi P; d'Angelo D; Avallone L; Galdiero M; Iovane G; Tortora G; Pagnini G
Res Vet Sci; 2000 Dec; 69(3):255-62. PubMed ID: 11124097
[TBL] [Abstract][Full Text] [Related]
36. Interferon therapies in small animals.
Mueller RS; Hartmann K
Vet J; 2021 May; 271():105648. PubMed ID: 33840487
[TBL] [Abstract][Full Text] [Related]
37. Type I interferons in the pathogenesis and treatment of canine diseases.
Klotz D; Baumgärtner W; Gerhauser I
Vet Immunol Immunopathol; 2017 Sep; 191():80-93. PubMed ID: 28895871
[TBL] [Abstract][Full Text] [Related]
38. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
39. The Use of Recombinant Feline Interferon Omega Therapy as an Immune-Modulator in Cats Naturally Infected with Feline Immunodeficiency Virus: New Perspectives.
Leal RO; Gil S
Vet Sci; 2016 Oct; 3(4):. PubMed ID: 29056740
[TBL] [Abstract][Full Text] [Related]
40. Hexadecylphosphocholine causes rapid cell death in canine mammary tumour cells.
Duijsings D; Houweling M; Vaandrager AB; Mol JA; Teerds KJ
Eur J Pharmacol; 2004 Oct; 502(3):185-93. PubMed ID: 15476744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
